Drug makers pull infant cough and cold meds from shelves—sort of
Hundreds of infant multi-symptom cough and cold medicines are being voluntarily pulled from drug store shelves in the wake of pressure from pediatricians and a call by FDA officials to ban the sale of cough and cold meds marketed for children under six.
You don't need a pill for every ill -- 80s Irish public service announcement rings true
Hat tip: edrugsearch blog
PAL coalition members push for SCHIP veto override
President Bush's veto of a bill to expand SCHIP, the State Children's Health Insurance Program, has been all over the news recently. The bill would have expanded health coverage to 3.8 million children who don't already have it.
A number of organizations
A conversation with Elissa Ladd, PhD FNP/GNP
Elissa Ladd’s career as a nurse practitioner has run parallel to the nursing field’s entry into the prescribing world. Ladd, who holds nursing degrees from the University of Pennsylvania and Rush University and a doctorate in health policy and nursing fr
1,300 Generic Drugs stuck waiting FDA approval -- FDA vows to speed up process
The New Jersey Star Ledger reports today, "FDA steps up generic drug program".
The FDA said it will step up a program giving priority and expedited review for drugs that currently have no generic alternative, and hopes to add new generic drug reviewers
FDA rebukes Lilly for Cymbalta promotion -- pigs fail to fly, hell remains unfrozen
The FDA Division of Drug Marketing, Advertising, and Communications has issued one of its increasingly rare enforcement letters, calling Eli Lilly (NYSE:LLY) to task for overstating the efficacy of its drug Cymbalta in a "professional mailer" sent to phy
MA health care hearing shows Rx foresight
The Prescription Project has been invited to testify before the joint committee on health care financing tomorrow at the Massachusetts State House. The hearing is on a set of 17 health care reform measures called “An Act Controlling Health Care Costs and
The FDA's blindspot in clinical trials oversight
A report by the Office of the Inspector General of Health and Human Services released today says that the FDA has shirked its duty to oversee federal clinical trials in this country in a big way. Fewer than 200 inspectors are responsible for auditing more
Supreme Court to hear two "preemption" cases
Readers of this blog know that we here often get our knickers in a twist over federal preemption arguments by pharmaceutical defendants seeking to avoid liability in lawsuits. Prescription drug and medical device companies have been arguing with increasi